EpiVax is now a member of Eurobiomed ,
a community bringing together scientific thought leaders with a common mission: Improve the health of all and as quickly as possible.
EpiVax, as a key player in the development of immunotherapies, will be in attendance at the B2B match event for Preclinical Development of Immunotherapies organized by Eurobiomed and MabDesign in Marseille, France.
Come network with us to discover our latest innovations!